Cargando…

Fluorescent risedronate analogue 800CW-pRIS improves tooth extraction-associated abnormal wound healing in zoledronate-treated mice

BACKGROUND: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a rare but serious side effect of nitrogen-containing bisphosphonate drugs (N-BPs) frequently prescribed to reduce skeletal-related events in bone malignancies and osteoporosis. BRONJ is associated with abnormal oral wound healin...

Descripción completa

Detalles Bibliográficos
Autores principales: Okawa, Hiroko, Kondo, Takeru, Hokugo, Akishige, Cherian, Philip, Sundberg, Oskar, Campagna, Jesus J., Kashemirov, Boris A., John, Varghese, Sun, Shuting, Ebetino, Frank H., McKenna, Charles E., Nishimura, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445170/
https://www.ncbi.nlm.nih.gov/pubmed/36082175
http://dx.doi.org/10.1038/s43856-022-00172-x
_version_ 1784783368235253760
author Okawa, Hiroko
Kondo, Takeru
Hokugo, Akishige
Cherian, Philip
Sundberg, Oskar
Campagna, Jesus J.
Kashemirov, Boris A.
John, Varghese
Sun, Shuting
Ebetino, Frank H.
McKenna, Charles E.
Nishimura, Ichiro
author_facet Okawa, Hiroko
Kondo, Takeru
Hokugo, Akishige
Cherian, Philip
Sundberg, Oskar
Campagna, Jesus J.
Kashemirov, Boris A.
John, Varghese
Sun, Shuting
Ebetino, Frank H.
McKenna, Charles E.
Nishimura, Ichiro
author_sort Okawa, Hiroko
collection PubMed
description BACKGROUND: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a rare but serious side effect of nitrogen-containing bisphosphonate drugs (N-BPs) frequently prescribed to reduce skeletal-related events in bone malignancies and osteoporosis. BRONJ is associated with abnormal oral wound healing after dentoalveolar surgery and tooth extraction. We previously found that N-BP chemisorbed to bone mineral hydroxyapatite was dissociated by secondary applied N-BP. This study investigated the effect of the surface equilibrium-based removal of N-BP from jawbone on tooth extraction wound healing of zoledronate (ZOL)-treated mice. METHODS: A pharmacologically inactive N-BP derivative (the 4-pyridyl isomer of risedronate equipped with a near-infrared 800CW fluorescent imaging dye, 800CW-pRIS) was designed and synthesized. 800CW-pRIS was intra-orally injected or topically applied in a deformable nano-scale vesicle formulation (DNV) to the palatal tissue of mice pretreated with ZOL, a potent N-BP. The female C56BL6/J mice were subjected to maxillary molar extraction and oral wound healing was compared for 800CW-pRIS/ZOL, ZOL and untreated control groups. RESULTS: 800CW-pRIS is confirmed to be inactive in inhibiting prenylation in cultured osteoclasts while retaining high affinity for hydroxyapatite. ZOL-injected mice exhibit delayed tooth extraction wound healing with osteonecrosis relative to the untreated controls. 800CW-pRIS applied topically to the jaw one week before tooth extraction significantly reduces gingival oral barrier inflammation, improves extraction socket bone regeneration, and prevents development of osteonecrosis in ZOL-injected mice. CONCLUSIONS: Topical pre-treatment with 800CW-RIS in DNV is a promising approach to prevent the complication of abnormal oral wound healing associated with BRONJ while retaining the anti-resorptive benefit of legacy N-BP in appendicular or vertebrate bones.
format Online
Article
Text
id pubmed-9445170
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-94451702022-09-07 Fluorescent risedronate analogue 800CW-pRIS improves tooth extraction-associated abnormal wound healing in zoledronate-treated mice Okawa, Hiroko Kondo, Takeru Hokugo, Akishige Cherian, Philip Sundberg, Oskar Campagna, Jesus J. Kashemirov, Boris A. John, Varghese Sun, Shuting Ebetino, Frank H. McKenna, Charles E. Nishimura, Ichiro Commun Med (Lond) Article BACKGROUND: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a rare but serious side effect of nitrogen-containing bisphosphonate drugs (N-BPs) frequently prescribed to reduce skeletal-related events in bone malignancies and osteoporosis. BRONJ is associated with abnormal oral wound healing after dentoalveolar surgery and tooth extraction. We previously found that N-BP chemisorbed to bone mineral hydroxyapatite was dissociated by secondary applied N-BP. This study investigated the effect of the surface equilibrium-based removal of N-BP from jawbone on tooth extraction wound healing of zoledronate (ZOL)-treated mice. METHODS: A pharmacologically inactive N-BP derivative (the 4-pyridyl isomer of risedronate equipped with a near-infrared 800CW fluorescent imaging dye, 800CW-pRIS) was designed and synthesized. 800CW-pRIS was intra-orally injected or topically applied in a deformable nano-scale vesicle formulation (DNV) to the palatal tissue of mice pretreated with ZOL, a potent N-BP. The female C56BL6/J mice were subjected to maxillary molar extraction and oral wound healing was compared for 800CW-pRIS/ZOL, ZOL and untreated control groups. RESULTS: 800CW-pRIS is confirmed to be inactive in inhibiting prenylation in cultured osteoclasts while retaining high affinity for hydroxyapatite. ZOL-injected mice exhibit delayed tooth extraction wound healing with osteonecrosis relative to the untreated controls. 800CW-pRIS applied topically to the jaw one week before tooth extraction significantly reduces gingival oral barrier inflammation, improves extraction socket bone regeneration, and prevents development of osteonecrosis in ZOL-injected mice. CONCLUSIONS: Topical pre-treatment with 800CW-RIS in DNV is a promising approach to prevent the complication of abnormal oral wound healing associated with BRONJ while retaining the anti-resorptive benefit of legacy N-BP in appendicular or vertebrate bones. Nature Publishing Group UK 2022-09-05 /pmc/articles/PMC9445170/ /pubmed/36082175 http://dx.doi.org/10.1038/s43856-022-00172-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Okawa, Hiroko
Kondo, Takeru
Hokugo, Akishige
Cherian, Philip
Sundberg, Oskar
Campagna, Jesus J.
Kashemirov, Boris A.
John, Varghese
Sun, Shuting
Ebetino, Frank H.
McKenna, Charles E.
Nishimura, Ichiro
Fluorescent risedronate analogue 800CW-pRIS improves tooth extraction-associated abnormal wound healing in zoledronate-treated mice
title Fluorescent risedronate analogue 800CW-pRIS improves tooth extraction-associated abnormal wound healing in zoledronate-treated mice
title_full Fluorescent risedronate analogue 800CW-pRIS improves tooth extraction-associated abnormal wound healing in zoledronate-treated mice
title_fullStr Fluorescent risedronate analogue 800CW-pRIS improves tooth extraction-associated abnormal wound healing in zoledronate-treated mice
title_full_unstemmed Fluorescent risedronate analogue 800CW-pRIS improves tooth extraction-associated abnormal wound healing in zoledronate-treated mice
title_short Fluorescent risedronate analogue 800CW-pRIS improves tooth extraction-associated abnormal wound healing in zoledronate-treated mice
title_sort fluorescent risedronate analogue 800cw-pris improves tooth extraction-associated abnormal wound healing in zoledronate-treated mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445170/
https://www.ncbi.nlm.nih.gov/pubmed/36082175
http://dx.doi.org/10.1038/s43856-022-00172-x
work_keys_str_mv AT okawahiroko fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice
AT kondotakeru fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice
AT hokugoakishige fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice
AT cherianphilip fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice
AT sundbergoskar fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice
AT campagnajesusj fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice
AT kashemirovborisa fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice
AT johnvarghese fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice
AT sunshuting fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice
AT ebetinofrankh fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice
AT mckennacharlese fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice
AT nishimuraichiro fluorescentrisedronateanalogue800cwprisimprovestoothextractionassociatedabnormalwoundhealinginzoledronatetreatedmice